[HTML][HTML] SARS-CoV-2 Omicron variant neutralization after mRNA-1273 booster vaccination
…, WP Black, I Gordon, M Guech… - … England Journal of …, 2022 - Mass Medical Soc
Omicron Neutralization and mRNA-1273 Boosters Neutralization of the omicron variant was
assessed in serum samples obtained from persons who had received an mRNA-1273 …
assessed in serum samples obtained from persons who had received an mRNA-1273 …
[HTML][HTML] Booster of mRNA-1273 strengthens SARS-CoV-2 Omicron neutralization
…, MR Gaudinski, WP Black, I Gordon, M Guech… - MedRxiv, 2021 - ncbi.nlm.nih.gov
The Omicron variant of SARS-CoV-2 is raising concerns because of its increased
transmissibility and potential for reduced susceptibility to antibody neutralization. To assess the …
transmissibility and potential for reduced susceptibility to antibody neutralization. To assess the …
[HTML][HTML] Booster of mRNA-1273 vaccine reduces SARS-CoV-2 Omicron escape from neutralizing antibodies
…, MR Gaudinski, WP Black, I Gordon, M Guech… - MedRxiv, 2021 - medrxiv.org
The Omicron variant of SARS-CoV-2 is raising concerns because of its increased
transmissibility and potential for reduced susceptibility to antibody neutralization. To assess the …
transmissibility and potential for reduced susceptibility to antibody neutralization. To assess the …
Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial
…, M Happe, L Strom, NM Berkowitz, M Guech… - The Lancet Infectious …, 2023 - thelancet.com
Background Human monoclonal antibodies might offer an important new approach to
reduce malaria morbidity and mortality. In the first two parts of a three-part clinical trial, the …
reduce malaria morbidity and mortality. In the first two parts of a three-part clinical trial, the …
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label …
…, B Flach, J Cox, A Beck, M Guech… - The Lancet Infectious …, 2023 - thelancet.com
Background Sudan Ebola virus can cause severe viral disease, with an average case fatality
rate of 54%. A recent outbreak of Sudan Ebola virus in Uganda caused 55 deaths among …
rate of 54%. A recent outbreak of Sudan Ebola virus in Uganda caused 55 deaths among …
[HTML][HTML] Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones
…, A Ahmed, L Novik, A Widge, I Gordon, M Guech… - Nature …, 2022 - nature.com
An important consequence of infection with a SARS-CoV-2 variant is protective humoral
immunity against other variants. However, the basis for such cross-protection at the molecular …
immunity against other variants. However, the basis for such cross-protection at the molecular …
AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology?
M Guech-Ongey, EP Simard… - Blood, The Journal …, 2010 - ashpublications.org
Trimodal or bimodal age-specific incidence rates for Burkitt lymphoma (BL) were observed
in the United States general population, but the role of immunosuppression could not be …
in the United States general population, but the role of immunosuppression could not be …
Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States
M Guech‐Ongey, EA Engels, JJ Goedert… - … journal of cancer, 2008 - Wiley Online Library
Squamous cell carcinoma of the conjunctiva (SCCC) has been associated with HIV infection
in equatorial Africa, but the evidence for association with HIV in developed countries, where …
in equatorial Africa, but the evidence for association with HIV in developed countries, where …
[HTML][HTML] HLA polymorphisms and detection of kaposi sarcoma-associated herpesvirus DNA in saliva and peripheral blood among children and their mothers in the …
M Guech-Ongey, M Verboom, RM Pfeiffer… - Infectious agents and …, 2010 - Springer
Kaposi sarcoma-associated herpesvirus (KSHV, also called Human herpesvirus 8 or HHV8)
is a γ-2 herpesvirus that causes Kaposi sarcoma. KSHV seroprevalence rates vary …
is a γ-2 herpesvirus that causes Kaposi sarcoma. KSHV seroprevalence rates vary …
Convergent epitope specificities, V gene usage and public clones elicited by primary exposure to SARS-CoV-2 variants
…, A Ahmed, L Novik, A Widge, I Gordon, M Guech… - bioRxiv, 2022 - biorxiv.org
While humoral immune responses to infection or vaccination with ancestral SARS-CoV-2 have
been well-characterized, responses elicited by infection with variants are less understood…
been well-characterized, responses elicited by infection with variants are less understood…